Use of coumarin derivatives for the preparation of drugs for treating skin diseases

Kallikrein proteolytic cascade plays a crucial role in various skin diseases. A series of coumarinic derivatives were identified with IC50 in the nanomolar range against kallikreins. Identified coumarinic derivatives are devoided of any cellular toxicity and demonstrated potent in vivo proteolysis inhibition

Keywords: Netherton syndrome
Patent Application number: European Procedure (Patents) (EPA) - 15 Juil. 2011 - 11 305 931.5
Inventors:
HOVNANIAN AlainREBOUD-RAVAUX MichèlePAGANO MauriceTAN XiaoQIN LixianPIROTTE BernardFURIO Laetitia
Publications:
Tan X. et al. J Med Chem. 2015 Jan 22;58(2):598-612

Reference:

BIO18503-T1

    Business Developper
    contact
    Aymeric Empereur
    Business Developer
    Patent filling date: null
    Rare disease: Yes
    Second indication: No

    You might also be interested in